HK1043732A1 - 利用煙霧狀抗生素治療嚴重慢性支氣管炎(支氣管擴張)的方法 - Google Patents

利用煙霧狀抗生素治療嚴重慢性支氣管炎(支氣管擴張)的方法

Info

Publication number
HK1043732A1
HK1043732A1 HK02104354.0A HK02104354A HK1043732A1 HK 1043732 A1 HK1043732 A1 HK 1043732A1 HK 02104354 A HK02104354 A HK 02104354A HK 1043732 A1 HK1043732 A1 HK 1043732A1
Authority
HK
Hong Kong
Prior art keywords
bronchiectasis
treatment
chronic bronchitis
severe chronic
aerosolized antibiotic
Prior art date
Application number
HK02104354.0A
Other languages
English (en)
Inventor
B Montgomery Alan
R Baker William
Original Assignee
Chiron Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiron Corp filed Critical Chiron Corp
Publication of HK1043732A1 publication Critical patent/HK1043732A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/7036—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin having at least one amino group directly attached to the carbocyclic ring, e.g. streptomycin, gentamycin, amikacin, validamycin, fortimicins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
HK02104354.0A 1998-12-17 2002-06-11 利用煙霧狀抗生素治療嚴重慢性支氣管炎(支氣管擴張)的方法 HK1043732A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11298498P 1998-12-17 1998-12-17
PCT/US1999/030234 WO2000035461A1 (en) 1998-12-17 1999-12-17 Method for the treatment of severe chronic bronchitis (bronchiectasis) with an aerosolized antibiotic

Publications (1)

Publication Number Publication Date
HK1043732A1 true HK1043732A1 (zh) 2002-09-27

Family

ID=22346930

Family Applications (1)

Application Number Title Priority Date Filing Date
HK02104354.0A HK1043732A1 (zh) 1998-12-17 2002-06-11 利用煙霧狀抗生素治療嚴重慢性支氣管炎(支氣管擴張)的方法

Country Status (15)

Country Link
US (1) US6387886B1 (zh)
EP (1) EP1161247A4 (zh)
JP (1) JP2002532430A (zh)
CN (1) CN1348377A (zh)
AU (1) AU778797B2 (zh)
BR (1) BR9916296A (zh)
CA (1) CA2355775A1 (zh)
CH (1) CH693763A5 (zh)
CZ (1) CZ20012147A3 (zh)
HK (1) HK1043732A1 (zh)
HU (1) HUP0105226A3 (zh)
NO (1) NO328594B1 (zh)
PL (1) PL348812A1 (zh)
SI (1) SI20959A (zh)
WO (1) WO2000035461A1 (zh)

Families Citing this family (57)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060165606A1 (en) * 1997-09-29 2006-07-27 Nektar Therapeutics Pulmonary delivery particles comprising water insoluble or crystalline active agents
TW465235B (en) 1998-09-17 2001-11-21 United Video Properties Inc Electronic program guide with digital storage
US20020061281A1 (en) * 1999-07-06 2002-05-23 Osbakken Robert S. Aerosolized anti-infectives, anti-inflammatories, and decongestants for the treatment of sinusitis
US6576224B1 (en) * 1999-07-06 2003-06-10 Sinuspharma, Inc. Aerosolized anti-infectives, anti-inflammatories, and decongestants for the treatment of sinusitis
US8336545B2 (en) 2000-05-05 2012-12-25 Novartis Pharma Ag Methods and systems for operating an aerosol generator
US7971588B2 (en) * 2000-05-05 2011-07-05 Novartis Ag Methods and systems for operating an aerosol generator
US8404217B2 (en) 2000-05-10 2013-03-26 Novartis Ag Formulation for pulmonary administration of antifungal agents, and associated methods of manufacture and use
US7871598B1 (en) 2000-05-10 2011-01-18 Novartis Ag Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
TWI290473B (en) 2000-05-10 2007-12-01 Alliance Pharma Phospholipid-based powders for drug delivery
NZ523693A (en) * 2000-07-10 2004-08-27 Chiron Corp Macrolide formulations for inhalation and methods of treatment of endobronchial infections
US7214364B2 (en) 2000-12-27 2007-05-08 Corus Pharma, Inc. Inhalable aztreonam lysinate formulation for treatment and prevention of pulmonary bacterial infections
EP1353647B1 (en) * 2000-12-27 2011-03-23 Gilead Sciences, Inc. Inhalable aztreonam for treatment and prevention of pulmonary bacterial infections
AU2007202942B2 (en) * 2001-05-18 2010-05-27 Novartis Ag Methods and unit dose formulations for the inhalation administration of aminoglycoside antibiotics
EP1598059A1 (en) * 2001-05-18 2005-11-23 Chiron Corporation Methods and unit dose formulations for the inhalation administration of aminoglycoside antibiotics
EP1320355B1 (en) * 2001-05-18 2006-04-05 Chiron Corporation System for delivering a tobramycin formulation
US20040022740A1 (en) * 2001-07-10 2004-02-05 Baker William R. Macrolide formulations for inhalation and methods of treatment of endobronchial infections
WO2003053411A1 (en) 2001-12-19 2003-07-03 Nektar Therapeutics Pulmonary delivery of aminoglycosides
US7607436B2 (en) * 2002-05-06 2009-10-27 The Research Foundation Of State University Of New York Methods, devices and formulations for targeted endobronchial therapy
US8245708B2 (en) * 2002-05-07 2012-08-21 The Research Foundation Of State University Of New York Methods, devices and formulations for targeted endobronchial therapy
WO2003101390A2 (en) * 2002-05-31 2003-12-11 Childrens Hospital And Regional Medical Center Endobronchial delivery of antibiotic in individuals with impaired lung tissue or lung function
US6966649B2 (en) * 2002-08-12 2005-11-22 John H Shadduck Adaptive optic lens system and method of use
US20070128124A1 (en) * 2002-09-12 2007-06-07 Kraus Carl N Aerosolized capreomycin for inhibition of pulmonary tuberculosis
EP1560540A4 (en) * 2002-10-18 2008-03-19 Molichem Medicines Inc METHOD FOR TREATING DRY EYES WITH LANTIBIOTICS
US7879351B2 (en) * 2002-10-29 2011-02-01 Transave, Inc. High delivery rates for lipid based drug formulations, and methods of treatment thereof
US7544369B2 (en) * 2002-10-29 2009-06-09 Transave, Inc. Sustained release of antiinfectives
US7718189B2 (en) 2002-10-29 2010-05-18 Transave, Inc. Sustained release of antiinfectives
RU2341267C2 (ru) * 2003-10-15 2008-12-20 Пари Фарма Гмбх Жидкий препарат, содержащий тобрамицин
WO2005107787A1 (en) * 2004-05-06 2005-11-17 Molichem Medicines, Inc. Treatment of membrane-associated diseases and disorders using lantibiotic containing compositions
EP1753445A4 (en) * 2004-05-06 2009-05-20 Molichem Medicines Inc TREATMENT OF EYE DISEASES AND EYE TREATMENTS WITH LANTIBIOTIC COMPOSITIONS
DK2316419T3 (da) 2004-05-17 2012-10-22 Gilead Sciences Inc Kombination af fosfomycin/tobramycin-aerosolform til behandling af bakterielle luftvejsinfektioner
DK1765288T3 (da) * 2004-06-18 2013-02-11 Novartis Ag Tobramycinpræparater til behandling af endobronchiale infektioner
AU2013206401B2 (en) * 2005-09-29 2016-06-23 Novartis Ag Antibiotic formulations, unit doses, kits, and methods
CA2622193A1 (en) * 2005-09-29 2007-04-12 Nektar Therapeutics Antibiotic formulations, unit doses, kits, and methods
CA2896083A1 (en) 2005-12-08 2007-06-14 Insmed Incorporated Lipid-based compositions of antiinfectives for treating pulmonary infections and methods of use thereof
JP5600432B2 (ja) * 2006-04-06 2014-10-01 インスメッド， インコーポレイテッド コアセルベート化誘導リポソーム被包法及びその調合物
JP2008199905A (ja) * 2007-02-16 2008-09-04 Snow Brand Milk Prod Co Ltd 乳酸菌生残性向上剤
WO2008137717A1 (en) 2007-05-04 2008-11-13 Transave, Inc. Compositions of multicationic drugs for reducing interactions with polyanionic biomolecules and methods and uses thereof
US9333214B2 (en) 2007-05-07 2016-05-10 Insmed Incorporated Method for treating pulmonary disorders with liposomal amikacin formulations
US9119783B2 (en) 2007-05-07 2015-09-01 Insmed Incorporated Method of treating pulmonary disorders with liposomal amikacin formulations
US9114081B2 (en) 2007-05-07 2015-08-25 Insmed Incorporated Methods of treating pulmonary disorders with liposomal amikacin formulations
WO2009049159A1 (en) 2007-10-10 2009-04-16 Parion Sciences, Inc. Delivering osmolytes by nasal cannula
EP2098219A1 (en) 2008-03-05 2009-09-09 PARI Pharma GmbH Macrolide compositions having improved taste and stability
EP3090792A1 (en) * 2008-07-18 2016-11-09 Prosonix Limited Process for improving crystallinity
CN106074461A (zh) * 2010-07-12 2016-11-09 赛利亚医药公司 通过氨基糖苷气雾给药治疗肺部感染
US8689439B2 (en) 2010-08-06 2014-04-08 Abbott Laboratories Method for forming a tube for use with a pump delivery system
US8377001B2 (en) 2010-10-01 2013-02-19 Abbott Laboratories Feeding set for a peristaltic pump system
US8377000B2 (en) 2010-10-01 2013-02-19 Abbott Laboratories Enteral feeding apparatus having a feeding set
AU2012267938B2 (en) 2011-06-07 2017-05-04 Parion Sciences, Inc. Methods of treatment
US8945605B2 (en) 2011-06-07 2015-02-03 Parion Sciences, Inc. Aerosol delivery systems, compositions and methods
US8826904B2 (en) 2011-07-12 2014-09-09 Cardeas Pharma Corporation Formulations of aminoglycoside and fosfomycin combinations and methods and systems for treatment of ventilator associated pneumonia (VAP) and ventilator associated tracheal (VAT) bronchitis
WO2013010041A1 (en) 2011-07-12 2013-01-17 Cardeas Pharma Inc. Formulations of amikacin and fosfomycin combinations and methods and systems for treatment of ventilator associated pneumonia (vap) and ventilator associated tracheal (vat) bronchitis
JP6402097B2 (ja) 2012-05-21 2018-10-10 インスメッド インコーポレイテッド 肺感染症を処置するためのシステム
CN102949379B (zh) * 2012-11-14 2014-11-05 中山大学 硫酸奈替米星吸入粉雾剂及其制备方法
RU2018135921A (ru) 2012-11-29 2019-02-05 Инсмед Инкорпорейтед Стабилизированные составы ванкомицина
CN104510726A (zh) * 2013-09-27 2015-04-15 张金华 一种用于清洁呼吸道系统的食盐干粉吸入剂
BR112016026699B1 (pt) 2014-05-15 2022-09-13 Insmed Incorporated Uso de uma composição farmaceutica de amicacina ou de um sal farmaceuticamente aceitável desta
JP7460534B2 (ja) 2018-03-30 2024-04-02 インスメッド インコーポレイテッド リポソーム医薬品の連続製造方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5141674A (en) * 1984-03-08 1992-08-25 Phares Pharmaceutical Research N.V. Methods of preparing pro-liposome dispersions and aerosols
US5512269A (en) * 1993-06-09 1996-04-30 Burroughs Wellcome, Co. Method of treating retained pulmonary secretions
US5522385A (en) * 1994-09-27 1996-06-04 Aradigm Corporation Dynamic particle size control for aerosolized drug delivery
US5508269A (en) * 1994-10-19 1996-04-16 Pathogenesis Corporation Aminoglycoside formulation for aerosolization

Also Published As

Publication number Publication date
CH693763A5 (de) 2004-01-30
CN1348377A (zh) 2002-05-08
NO20012978L (no) 2001-08-15
SI20959A (sl) 2003-02-28
HUP0105226A2 (hu) 2002-04-29
CZ20012147A3 (cs) 2003-01-15
NO328594B1 (no) 2010-03-29
AU2370100A (en) 2000-07-03
JP2002532430A (ja) 2002-10-02
CA2355775A1 (en) 2000-06-22
BR9916296A (pt) 2004-06-29
EP1161247A4 (en) 2002-05-15
NO20012978D0 (no) 2001-06-15
PL348812A1 (en) 2002-06-17
EP1161247A1 (en) 2001-12-12
AU778797B2 (en) 2004-12-23
WO2000035461A1 (en) 2000-06-22
HUP0105226A3 (en) 2003-03-28
US6387886B1 (en) 2002-05-14

Similar Documents

Publication Publication Date Title
HUP0105226A3 (en) Method for the treatment of severe chronic bronchitis (bronchiectasis) with an aerosolized antibiotic
AU746978C (en) Composition for fire-protection coating
AU6771798A (en) Method for treatment of chronic bronchitis
AU3869200A (en) Method and composition for masking mineral taste
AU1712600A (en) Methods for reducing the flammability of cellulosic substrates
AU6260999A (en) Methods of treating chronic pain
AU6047099A (en) Compositions and methods for the treatment of chronic lymphocytic leukemia
AU3444899A (en) Method for the rapid determination of bacteria
AU4973799A (en) Methods for plasma modification of substrates
AU5331199A (en) Method for the production of an antibiotic agent
AU1817700A (en) 1-carboxymethyl-2-oxo-azepan derivatives useful as selective inhibitors of mmp-12
AU6359598A (en) Method for treating protozoal infections
AUPM360694A0 (en) In-line galvanizing process
AU1735800A (en) Method of treating seizure disorders
HUP0100784A3 (en) Streptomyces avermitilis gene directing the ratio of b2:b1 avermectins
AU2520299A (en) Method for the determination of prosthetic infections
AU2430600A (en) Coating agent and method for its production
AU3103097A (en) Compositions and methods for the treatment of chronic infections
AU1719700A (en) Selective inhibitors of mmp-12
AU2599399A (en) Method of treating migraine
AUPP375198A0 (en) An anticorrosion treatment
AU2026299A (en) Method for treating multiple sclerosis
AU6393499A (en) Methods for reducing the flammability of cellulosic substrates
AU7108998A (en) Method for treating fungal infections
AU5432599A (en) Treatment of vasodilatory headache